CTOs on the Move

Heathrow Scientific

www.heathrowscientific.com

 
Heathrow Scientific is a Vernon Hills, IL-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
  • Number of Employees: 25-100
  • Annual Revenue: $10-50 Million

Executives

Name Title Contact Details

Similar Companies

INRAD

INRAD, Inc. is one of the leading companies in Healthcare, Pharmaceuticals, and Biotech industry. INRAD, Inc. is based in Northvale, NJ. You can find more information on INRAD, Inc. at www.inrad.com

Ariosa Diagnostics

Ariosa Diagnostics, Inc. is a molecular diagnostics company committed to innovating together to improve patient care. The flagship product, the Harmony™ Prenatal Test, is a safe, highly accurate and affordable prenatal test for maternal and fetal health. Led by an experienced team, Ariosa is using its proprietary technology to perform a directed analysis of cell-free DNA in blood. The Harmony™ Prenatal Test equips pregnant women and their healthcare providers with reliable information to make decisions regarding their health, without creating unnecessary stress or anxiety.

Smart Choice MRI

At Smart Choice MRI, we put your comfort and convenience first. That doesn`t just mean giving you a scan using advanced GE technology and the expert interpretation by a Cleveland Clinic radiologist, for a fraction of what it would cost at a hospital. That means working with your schedule, offering early morning, evening, and weekend appointments, and doing whatever we can to make your scan a relaxing, comfortable experience.

St. Luke's Hospital and Health Network

St. Luke's Hospital and Health Network is one of the leading providers in Healthcare, Pharmaceuticals, and Biotech. It is based in Bethlehem, PA. To find more information about St. Luke's Hospital and Health Network, please visit www.slhn.org

HedgePath Pharmaceuticals

HedgePath Pharmaceuticals, Inc. is a clinical stage biopharmaceutical company that discovers, develops and plans to commercialize innovative therapeutics for patients with cancer. The Company may also explore acquiring or licensing innovative therapeutics addressing unmet needs and orphan indications beyond cancer. We are focused on the development of therapies for more than one type of cancer, with initial emphasis in the U.S. market, based upon repurposing the currently marketed antifungal drug itraconazole for new indications in oncology.